DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: OCREVUS (ocrelizumab)
       *****************************************************
       #Post#: 3359--------------------------------------------------
       (Abst.) Clinical outcomes of patients w/MS treated w/Ocrevus...
       By: agate Date: July 27, 2021, 7:01 pm
       ---------------------------------------------------------
       From PubMed (July 27, 2021)--"Clinical outcomes of patients with
       multiple sclerosis treated with ocrelizumab in a US community MS
       center: An observational study":
  HTML https://pubmed.ncbi.nlm.nih.gov/34308352/
       #Post#: 3389--------------------------------------------------
       Ocrevus reduces MS relapse risk, but linked to more hospitalizat
       ions
       By: agate Date: August 26, 2021, 10:56 pm
       ---------------------------------------------------------
       An article about this study in Multiple Sclerosis News Today
       (August 25, 2021)--"Ocrevus reduces MS relapse risk, but linked
       to more hospitalizations":
  HTML https://bit.ly/2WsvVA2
       
       *****************************************************